Call : +918068096635
|Home||» Products||» Oncology Drugs|
Oncology Drugs are prescribed for the treatment of myelodysplastic syndromes and certain types of cancers. They comprise erlotinib, fulvestrant, & decitabine as active compounds in precise compositions that exert targeted mode of action and assure high reliability. These drugs are consumed orally or administered via intravenous route as prescribed by the doctor. They work by directly inhibiting angiogenesis by serving as tumor necrosis factor inhibitors. These medicines are mostly metabolized in the liver by CYP1A2, CYP3A4, CYP2C19, CYP2D6. They are also effective for the treatment of HER-2 positive breast cancer in menopausal women. These drugs are clinically tested on several parameters for ensuring safety of use.